Doxycycline causes regression of endometriotic implants: a rat model
article
OA: closed
CC0
⤵ 12 in-corpus citations
AI-generated summary
Doxycycline treatment significantly reduced endometriotic implant size and MMP expression in a rat model, with low-dose Dox also decreasing IL-6 levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
BACKGROUND: Doxycycline (Dox) has a number of non-antibiotic properties. One of them is the inhibition of matrix metalloproteinase (MMP) activity. The aim of this study was to assess the effects of Dox in a rat endometriosis model. METHODS: Endometriosis was surgically induced in 40 rats by transplanting of endometrial tissue. After 3 weeks, repeat laparotomies were performed to check the implants and the animals were randomized into four groups: Group I, low-dose Dox (5 mg/kg/day); Group II, high-dose Dox (40 mg/kg/day); Group III, leuprolide acetate 1 mg/kg single dose, s.c.; and Group VI (controls), no medication. The treatment, initiated on the day of surgery and continuing for 3 weeks, was administered to the study groups. Three weeks later, the rats were euthanized and the implants were evaluated morphologically and histologically for immunoreactivity of MMP-2 and -9, and interleukin-6 (IL-6) concentration in the peritoneal fluid was assayed. RESULTS: Treatment with leuprolide acetate, or high-dose or low-dose Dox caused significant decreases in the implant areas compared with the controls (P = 0.03, P = 0.006, and P = 0.001, respectively). IL-6 levels in peritoneal fluid decreased in Group I (P = 0.02) and Group III (P < 0.05). MMP H scores were significantly lower in the group that received low-dose Dox in both epithelial and stromal MMP-2 and -9 immunostaining when compared with the control group [P = 0.048, P = 0.002, P = 0.007 and P = 0.002, respectively, MMP-2 (epithelia), MMP-2 (stroma), MMP-9 (epithelia) and MMP-9 (stroma)]. CONCLUSIONS: Low-dose Dox caused regression of endometriosis in this experimental rat model.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (96)
- Anastrazole and oral contraceptives: a novel treatment for endometriosis via openalex
- Angiogenesis extent and expression of matrix metalloproteinase‐2 and ‐9 agree with progression of ovarian endometriomas via openalex
- Angiostatic agents prevent the development of endometriosis-like lesions in the chicken chorioallantoic membrane via openalex
- Association of interleukin‐6 and estradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis via openalex
- Combination of estrogen and dioxin is involved in the pathogenesis of endometriosis by promoting chemokine secretion and invasion of endometrial stromal cells via openalex
- Differential interleukin-6 messenger ribonucleic acid expression and its distribution pattern in eutopic and ectopic endometrium via openalex
- Differential Regulation of Matrix Metalloproteinase-3 Gene Expression in Endometriotic Lesions Compared with Endometrium1 via openalex
- Down-Regulation of Endometrial Matrix Metalloproteinase-3 and -7 Expression<i>in Vitro</i>and Therapeutic Regression of Experimental Endometriosis<i>in Vivo</i>by a Novel Nonsteroidal Progesterone Receptor Agonist, Tanaproget via openalex
- Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis via openalex
- Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. via openalex
- Evidence for an increased release of proteolytic activity by the eutopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9 via openalex
- Expression of metalloproteinase-9 in ectopic endometrium in women with endometriosis. via openalex
- Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis via openalex
- [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium]. via openalex
- Extracellular matrix remodelling in the endometrium and its possible relevance to the pathogenesis of endometriosis via openalex
- Genistein causes regression of endometriotic implants in the rat model via openalex
- Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas via openalex
- Increased expression of c-fos protein associated with increased matrix metalloproteinase-9 protein expression in the endometrium of endometriotic patients via openalex
- Increased expression of matrix metalloproteinase-9 in the eutopic endometrial tissue of women with endometriosis via openalex
- Increased peritoneal and endometrial gene expression of biologically relevant cytokines and growth factors during the menstrual phase in women with endometriosis via openalex
- Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model via openalex
- Interferon‐Gamma (IFN‐γ) and Interleukin‐6 (IL‐6) in Peritoneal Fluid and Macrophage‐Conditioned Media of Women With Endometriosis via openalex
- Interleukin-6: another piece of the endometriosis-cytokine puzzle via openalex
- Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium via openalex
- Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: a rationale for endometriotic invasiveness via openalex
- Paracrine Regulation of Matrix Metalloproteinase Expression in Endometriosis via openalex
- Paracrine Regulation of Matrix Metalloproteinase Expression in the Normal Human Endometrium via openalex
- Pathological evaluation of the rat endometriosis model via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial via openalex
- Regression of endometrial explants in rats treated with the cyclooxygenase-2 inhibitor rofecoxib via openalex
- Selective Progesterone Receptor Modulator Development and Use in the Treatment of Leiomyomata and Endometriosis via openalex
- Steroid and Cytokine Regulation of Matrix Metalloproteinase Expression in Endometriosis and the Establishment of Experimental Endometriosis in Nude Mice via openalex
- Suppression of Matrix Metalloproteinase-9 by Prostaglandin E2 in Peritoneal Macrophage Is Associated with Severity of Endometriosis via openalex
- The follicular and endocrine environment in women with endometriosis: local and systemic cytokine production via openalex
- W2053321628 via openalex
- W2066700182 via openalex
- W2073595123 via openalex
- W2073597522 via openalex
- W2079801336 via openalex
- W2079862741 via openalex
- W2081117740 via openalex
- W2102404503 via openalex
- W2102732690 via openalex
- W2111275713 via openalex
- W2111497869 via openalex
- W2112753909 via openalex
- W2116969857 via openalex
- W2117420688 via openalex
- W2117753922 via openalex
- W2120212237 via openalex
- W2124600315 via openalex
- W2128930486 via openalex
- W2133184547 via openalex
- W2136348600 via openalex
- W2143715300 via openalex
- W2151591273 via openalex
- W2161052815 via openalex
- W2165476491 via openalex
- W2171863626 via openalex
- W92822971 via openalex
- W4376544320 via openalex
- W119090754 via openalex
- W1262682589 via openalex
- W1497141930 via openalex
- W1886431664 via openalex
- W1938535455 via openalex
- W1968256243 via openalex
- W1969169755 via openalex
- W1971586374 via openalex
- W1972229497 via openalex
- W1973990678 via openalex
- W1975593847 via openalex
- W1975722608 via openalex
- W1976295332 via openalex
- W1979323310 via openalex
- W1979978633 via openalex
- W1981277384 via openalex
- W1981390055 via openalex
- W1984483611 via openalex
- W1987748412 via openalex
- W1990858735 via openalex
- W1999272236 via openalex
- W2012551574 via openalex
- W2016037432 via openalex
- W2019264775 via openalex
- W2020867804 via openalex
- W2030776545 via openalex
- W2031000899 via openalex
- W2031006686 via openalex
- W2031602204 via openalex
- W2035813865 via openalex
- W2036038049 via openalex
- W2038981906 via openalex
- W2050733976 via openalex
- W2051209405 via openalex
Cited by (12)
- Applications of nanomaterials in endometriosis treatment 2023
- The effect of carbamazepine, which increases oestrogen destruction, on the endometriotic implants; an experimental rat model 2021
- Doxycycline reduces MMP-2 activity and inhibits invasion of 12Z epithelial endometriotic cells as well as MMP-2 and -9 activity in primary endometriotic stromal cells in vitro 2019
- Influência da doxiciclina em endometriose experimentalmente induzida em ratas 2018
- Relevant human tissue resources and laboratory models for use in endometriosis research 2017
- A Prospective Randomized Experimental Study to Investigate the Eradication Rate of Endometriosis after Surgical Resection versus Aerosol Plasma Coagulation in a Rat Model 2016
- The Impact of Endometriosis on Fertility 2015
- Effect of the non-specific matrix metalloproteinase inhibitor Doxycycline on endometriotic implants in an experimental rat model 2015
- Emerging treatment of endometriosis 2015
- Endometriosis 2013
- Potential cures for endometriosis 2011
- Therapeutic Efficiency of Tibolone in a Rat Endometriosis Model 2011
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:14:11.755070+00:00
License: CC0
· commercial use OK